As of 2025-06-19, the Fair Value of Vor Biopharma Inc (VOR) is -3.86 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.21 USD, the upside of Vor Biopharma Inc is -1,974.22%.
With the market price of 0.21 USD and our fair value calculation, Vor Biopharma Inc (VOR) is not a good investment. Investing in VOR stocks now will result in a potential loss of 1,974.22%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -43.34 | -68.90 | -92.09 | -117.86 | -116.91 | -87.82 |
| YoY growth | -299.82% | -58.98% | -33.66% | -27.99% | 0.81% | -83.93% |
| Market Cap (mil) | 31.64 |
| P/E | |
| Forward P/E |
| EPS | -0.77 |
| Avg earnings growth rate | -83.93% |
| TTM earnings | -118.60 |